Loading organizations...
Loading organizations...
Developing First-in-Class SGK agonists for rare eye diseases.
Bionure has raised $4.7M across 1 funding round.
Bionure has raised $4.7M in total across 1 funding round.
Bionure has raised $4.7M in total across 1 funding round.
Bionure's investors include Montserrat Vendrell.
Bionure has raised $4.7M across 1 funding round. Most recently, it raised $4.7M Series A in May 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 17, 2018 | $4.7M Series A | Montserrat Vendrell |